Publication:
Distinct disease-sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients.

dc.contributor.authorSanchez-Mejias, Elisabeth
dc.contributor.authorNuñez-Diaz, Cristina
dc.contributor.authorSanchez-Varo, Raquel
dc.contributor.authorGomez-Arboledas, Angela
dc.contributor.authorGarcia-Leon, Juan Antonio
dc.contributor.authorFernandez-Valenzuela, Juan Jose
dc.contributor.authorMejias-Ortega, Marina
dc.contributor.authorTrujillo-Estrada, Laura
dc.contributor.authorBaglietto-Vargas, David
dc.contributor.authorMoreno-Gonzalez, Ines
dc.contributor.authorDavila, Jose Carlos
dc.contributor.authorVitorica, Javier
dc.contributor.authorGutierrez, Antonia
dc.date.accessioned2024-02-10T20:02:19Z
dc.date.available2024-02-10T20:02:19Z
dc.date.issued2019-10-09
dc.description.abstractNeuronal loss is the best neuropathological substrate that correlates with cortical atrophy and dementia in Alzheimer's disease (AD). Defective GABAergic neuronal functions may lead to cortical network hyperactivity and aberrant neuronal oscillations and in consequence, generate a detrimental alteration in memory processes. In this study, using immunohistochemical and stereological approaches, we report that the two major and non-overlapping groups of inhibitory interneurons (SOM-cells and PV-cells) displayed distinct vulnerability in the perirhinal cortex of APP/PS1 mice and AD patients. SOM-positive neurons were notably sensitive and exhibited a dramatic decrease in the perirhinal cortex of 6-month-old transgenic mice (57% and 61% in areas 36 and 35, respectively) and, most importantly, in AD patients (91% in Braak V-VI cases). In addition, this interneuron degenerative process seems to occur in parallel, and closely related, with the progression of the amyloid pathology. However, the population expressing PV was unaffected in APP/PS1 mice while in AD brains suffered a pronounced and significant loss (69%). As a key component of cortico-hippocampal networks, the perirhinal cortex plays an important role in memory processes, especially in familiarity-based memory recognition. Therefore, disrupted functional connectivity of this cortical region, as a result of the early SOM and PV neurodegeneration, might contribute to the altered brain rhythms and cognitive failures observed in the initial clinical phase of AD patients. Finally, these findings highlight the failure of amyloidogenic AD models to fully recapitulate the selective neuronal degeneration occurring in humans.
dc.format.number2es_ES
dc.format.page345-363es_ES
dc.format.volume30es_ES
dc.identifier.doi10.1111/bpa.12785
dc.identifier.e-issn1750-3639es_ES
dc.identifier.journalBrain pathology (Zurich, Switzerland)es_ES
dc.identifier.otherhttp://hdl.handle.net/10668/14476
dc.identifier.pubmedID31491047es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17918
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAlzheimer
dc.subjectGABA
dc.subjectHuman brain
dc.subjectInterneuron
dc.subjectParvalbumin
dc.subjectSomatostatin
dc.subjectTransentorhinal cortex
dc.subjectTransgenic mouse
dc.subject.meshAged
dc.titleDistinct disease-sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files